Evidence map›Paper›PMID 35055743›Full record

ArticleInternational journal of environmental research and public health2022

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders.

Deborah Dal Farra, Alice Valdesalici, Giancarlo Zecchinato, Alfio De Sandre, Diego Saccon, Pierluigi Simonato, Ornella Corazza, Giovanni Martinotti, Andrew L Smith, Marco Solmi

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Deborah Dal FarraDepartment of General Psychology, University of Padua, 35122 Padova, Italy.
Alice ValdesaliciDepartment of General Psychology, University of Padua, 35122 Padova, Italy.ORCID 0000-0003-2725-3895
Giancarlo ZecchinatoAddiction Department, AULSS 6 Euganea, 35131 Padova, Italy.
Alfio De SandreAddiction Department, AULSS 1 Dolomiti, 32021 Agordo, Italy.
Diego SacconAddiction Department, AULSS 4 Veneto Orientale, 30027 San Donà di Piave, Italy.
Pierluigi SimonatoParco dei Tigli, 35037 Teolo, Italy.
Ornella CorazzaSchool of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK.ORCID 0000-0001-7371-319X
Giovanni MartinottiSchool of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK.ORCID 0000-0002-7292-2341
Andrew L SmithDepartment of Psychiatry, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Marco SolmiDepartment of Psychiatry, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
University of Hertfordshire · GBUniversity of Ottawa · CAUniversity of Padua · ITOspedale di San Donà di Piave · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to determine prevalence and frequency of use of novel psychoactive substances (NPS) and to identify the factors associated with NPS use in an Italian sample of patients diagnosed with substance use disorder (SUD). Prevalence and correlates of NPS knowledge and use were assessed in 185 patients with SUD in three addiction services (Padova, Belluno, Feltre) in the Veneto region with an ad-hoc designed survey. Two thirds of the samples reported knowing NPS and one third reported using them. NPS were considered by them less dangerous than "regular" substances of abuse (t = 6.06 mean 0.78,

Indexed as

Psychotropic DrugsSubstance-Related DisordersAdolescentComorbidityHumansItalyPrevalencePsychotropic Drugsaddiction servicesnovel psychoactive substancesprevalencerisk factorssubstance use disorder

Identifiers

PMID35055743
PMCPMC8776073
OpenAlexW4206700364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.